Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Postoperative Seizures After Brain Tumor Surgery × Levetiracetam × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Seizures 2 Brain Neoplasms 2 beta-Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Seizures After Brain Tumor Surgery 1 Neurofibromatosis 1 1 Neuroblastoma 1 Neoplasm, Residual 1 Necrosis 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Influenza, Human 1 Hematologic Neoplasms 1 Chromosome Aberrations 1 Chromosome 7, monosomy 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Levetiracetam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07239115 2025-11-20

PREVENT

Beijing Tiantan Hospital

Phase 3 Not yet recruiting

Postoperative Seizures After Brain Tumor Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡